Delivering next-generation treatments for back of the eye disorders, with focus on diabetic eye disease

Results of a Phase 1, Open Label, Dose Escalation Study of THR-149 for the Treatment of DME

Dr. Pravin Dugel: "Results of a Phase 1, Open Label, Dose Escalation Study of THR-149 for the Treatment of DME". London, 15 September 2019.

Publication date: 
September, 2019
Attachment: 
PDF icon THR-149-001_ Retina Society PDugel_15Sep2019.pdf